ilaprazole: Clinical Trials

7 trials of ilaprazole, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed, 1 not yet recruiting, 1 unknown. 7 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 47Completed 5, Not yet recruiting 1, Unknown 1

Follow ilaprazole: new trials by email Literature Review of ilaprazole trials Research Report on ilaprazole

Trials (filtered) newest first · largest first

All 7 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Efficacy of Proton Pump Inhibitors in Cirrhotic Patients With Acute Variceal Bleeding
Proton Pump Inhibitors, No Proton Pump Inhibitors - Upper Gastrointestinal Hemorrhage
Phase 4Not yet recruitingWest China Hospital6722023-10-012023-09-28
Antimicrobial Susceptibility Testing Guided Triple Therapy in Salvage Helicobacter Pylori Treatment
amoxicillin, clarithromycin, tinidazole - Antimicrobial Susceptibility Testing, Triple Therapy
Phase 4UnknownYanqing Li1202017-05-302017-05-03
The Pilot Study on Tailored Eradication Therapy According to Clarithromycin Resistance in H.Pylori Patients
Ilaprazole, Amoxicillin, Clarithromycin - Peptic Ulcer
Phase 4CompletedKyungpook National University Hospital502016-03-022018-08-09
Effects of Ilaprazole on Ulcer Healing Rate and Prevention of Gastrointestinal Bleeding in the Patients Undergone ESD.
Ilaprazole, Rabeprazole - Gastric Cancer
Phase 4CompletedIl-Yang Pharm. Co., Ltd.1762015-12-012020-07-31
Dual Therapy With High Doses of Ilaprazole and Amoxicillin for Helicobacter Pylori Infection
Ilaprazole + Amoxicillin - Helicobacter Infections
Phase 4CompletedIl-Yang Pharm. Co., Ltd.902014-12-012015-11-03
Efficacy and Safety of 1-week Triple Therapy With Ilaprazole for the Eradication of Helicobacter Pylori
Ilaprazole, Esoprazole - Helicobacter Pylori Eradication
Phase 4CompletedLivzon Pharmaceutical Group Inc.2014-09-012016-08-19
The Prospective Study on the Effect of Ilaprazole in Non-erosive Reflux Disease Patients; Focused on Histologic Findings and Inflammatory Biomarker
Ilaprazole - Gastrointestinal Subepithelial Tumors
Phase 4CompletedYonsei University202014-07-012019-03-22

Conditions studied

Gastroesophageal Reflux (1)  ·  Gastrointestinal Hemorrhage (1)  ·  Helicobacter Infections (1)  ·  Liver Cirrhosis (1)  ·  Peptic Ulcer (1)  ·  Stomach Neoplasms (1)

Sponsors

Il-Yang Pharm. Co., Ltd. (2)  ·  Kyungpook National University Hospital (1)  ·  Livzon Pharmaceutical Group Inc. (1)  ·  West China Hospital (1)  ·  Yanqing Li (1)  ·  Yonsei University (1)

Countries

South Korea (3)

Top investigators

ChangSeok Bang, MD, PhD (1)  ·  Li Yanqing, MD, PhD (1)  ·  Seong Woo Jeon (1)  ·  YoonJeong Lim, MD, PhD (1)

Results publications

PMID 30167954